title: [III. Molecular targeting therapy for glioma-bevacizumab and cilengitide].
authors: Kazuhiko
authors: K
authors: Kurozumi
authors: Manabu
authors: M
authors: Onishi
authors: Tomotsugu
authors: T
authors: Ichikawa
authors: Kentaro
authors: K
authors: Fujii
authors: Jyouji
authors: J
authors: Ishida
authors: Yousuke
authors: Y
authors: Shimazu
authors: Isao
authors: I
authors: Date
mesh_terms: D043925:Angiogenesis Inducing Agents / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000068258:Bevacizumab; D002986:Clinical Trials as Topic; D005910:Glioma / Q000188:drug therapy*; D006801:Humans; D058990:Molecular Targeted Therapy; D012910:Snake Venoms / Q000627:therapeutic use*
chemical_list: D043925:Angiogenesis Inducing Agents; D061067:Antibodies, Monoclonal, Humanized; D012910:Snake Venoms; D000068258:Bevacizumab; C422910:Cilengitide